MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $792,193 | +96.3% | 33,596 | +53.2% | 0.00% | – |
| Q2 2023 | $403,476 | 0.0% | 21,928 | 0.0% | 0.00% | – |
| Q1 2023 | $403,476 | +18.9% | 21,928 | 0.0% | 0.00% | – |
| Q4 2022 | $339,226 | -99.9% | 21,928 | 0.0% | 0.00% | – |
| Q3 2022 | $439,218,000 | -11.5% | 21,928 | 0.0% | 0.00% | – |
| Q2 2022 | $496,450,000 | +17.5% | 21,928 | +37.2% | 0.00% | – |
| Q1 2022 | $422,537,000 | +64.8% | 15,981 | +98.2% | 0.00% | – |
| Q4 2021 | $256,372,000 | +23.9% | 8,062 | -31.7% | 0.00% | – |
| Q4 2020 | $206,854,000 | +46.1% | 11,800 | 0.0% | 0.00% | – |
| Q3 2020 | $141,600,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,424,000 | 19.47% |
| BVF INC/IL | 7,285,071 | $152,185,000 | 5.71% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 244,713 | $5,112,000 | 2.79% |
| Burrage Capital Management LLC | 130,683 | $2,730,000 | 2.21% |
| MPM BioImpact LLC | 700,879 | $14,641,000 | 1.84% |
| Sofinnova Investments, Inc. | 1,311,039 | $27,388,000 | 1.65% |
| Octagon Capital Advisors LP | 200,000 | $4,178,000 | 1.57% |
| Boxer Capital, LLC | 1,900,000 | $39,691,000 | 1.35% |
| DAFNA Capital Management LLC | 157,841 | $3,297,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,113,706 | $23,265,000 | 0.34% |